[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"OvationLab\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":128},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,41,62,87,111],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100651018","prospective-human-study-evaluating-changes-in-markers-of-detoxification-overall-physical-and-mental-health-and-fatigue-following-supplementation-with-cellcore-protocols-100651018",false,"NCT07753798","Prospective Human Study Evaluating Changes in Markers of Detoxification, Overall Physical and Mental Health, and Fatigue Following Supplementation With CellCore Protocols","Inclusion Criteria:\n\n1. Adult between 25 and 65 years of age\n2. Documented elevated urinary environmental toxicant levels above the 75th percentile of at least 5 toxins on baseline environmental toxin test\n3. PROMIS - Global Health - Physical Health t-scores \\\u003C 42.4 for Foundational Protocol (otherwise BioToxin Binder\u002FDrainage Activator Protocol)\n4. Currently receiving care from a qualified, participating practitioner\n5. Lives in the United States\n6. Ability to speak and read English\n7. Willing and able to follow the assigned CellCore protocols and complete all required testing and questionnaires\n8. Willing and able to provide informed consent\n\nExclusion Criteria:\n\n1. Currently undergoing active chelation therapy\n2. Participation in a structured detoxification program within the prior 60 days, including use of activated charcoal, bentonite\u002Fzeolite clay, chlorella, cholestyramine\n3. Ongoing occupational toxic exposure (e.g., working on golf course, dry cleaning facility) that cannot be reduced or controlled during the study period\n4. Pregnancy or lactation, or planning pregnancy during the study period\n5. Major comorbid medical condition requiring complex specialty management that, in the practitioners' clinical judgment, would interfere with safe study participation\n6. Anticipated initiation of additional detoxification products, major dietary changes, or other significant co-interventions during the study period\n7. Unable or unwilling to provide informed consent","ALL","25 Years","65 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"NA","The primary purpose of this study is to evaluate the effects of CellCore protocols on environmental toxicant biomarkers among adult patients with high baseline toxicant levels. Patients will be allocated to one of two CellCore protocols (Foundational Protocol or BioToxin Binder\u002FDrainage Activator) based on overall physical health, mental health, and fatigue levels at baseline.\n\nA prospective, practitioner-led, open-label, single-arm intervention with the CellCore protocols will be conducted to measure pre- and post-intervention changes in urinary environmental toxicant biomarkers and validated, patient-reported health outcomes.",[26,27],"Environmental Toxins","General Health","NOT_YET_RECRUITING","2026-08-01",{"date":31,"type":32},"2026-08-10","ACTUAL",{"date":34,"type":20},"2026-08",{"date":36,"type":20},"2027-06",{"name":38,"class":39},"OvationLab","NETWORK",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":15,"minAge":47,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":59,"leadSponsor":61,"locationsCount":40},"100648196","open-label-clinical-trial-evaluating-the-impact-of-a-multi-strain-commensal-probiotic-dietary-supplement-on-gastrointestinal-microbiota-composition-functional-gastrointestinal-markers-and-gastrointestinal-symptoms-100648196","NCT07720362","Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms","Inclusion Criteria:\n\n1. Adult females or males age ≥ 18 years\n2. At least moderate gastrointestinal distress, defined as a score of ≥ 4 on any domain of the Gastrointestinal Symptoms Rating Scale (GSRS) at screening\n3. Ability to read and speak English\n4. Ability and willingness to collect an at-home stool sample for GI-MAP testing\n\nExclusion Criteria:\n\n1. Current or recent (within the prior 90 days) use of a probiotic dietary supplement\n2. Current or recent (within the prior 90 days) use of systemic antibiotics, antifungals, or antiparasitic medications\n3. Known allergies to any ingredients in the product\n4. Currently pregnant or lactating women or women planning to become pregnant in the next 8 weeks\n5. Current diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis), celiac disease, active gastrointestinal malignancy, or other chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol\n6. Severely immunocompromised status (e.g., active chemotherapy, post-transplant immunosuppression, advanced HIV)\n7. Participants unable to provide consent","18 Years",{"count":49,"type":20},25,[23],"A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.",[53,54],"Gastrointestinal","Microbiota","2026-07-21",{"date":57,"type":32},"2026-07-23",{"date":55,"type":20},{"date":60,"type":20},"2026-11",{"name":38,"class":39},{"id":63,"slug":64,"hasResults":11,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":4,"eligibilityCriteria":67,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":68,"targetDuration":70,"studyType":71,"phases":4,"briefSummary":72,"conditions":73,"keywords":76,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":40},"100640109","associations-between-household-mold-levels-and-physical-and-mental-health-a-mold-and-mycotoxin-testing-research-registry-100640109","NCT07605078","Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry","Inclusion Criteria:\n\n* All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.\n\nExclusion Criteria:\n\n* Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.",{"count":69,"type":20},2500,"5 Years","OBSERVATIONAL","The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.",[74,75],"Mold Illness","Mold or Dust Allergy",[77],"Mold","RECRUITING","2026-07-02",{"date":81,"type":32},"2026-07-07",{"date":83,"type":32},"2026-04-27",{"date":85,"type":20},"2029-04",{"name":38,"class":39},{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":93,"sex":15,"minAge":94,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":21,"phases":97,"briefSummary":98,"conditions":99,"keywords":4,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":40},"100640688","clinical-trial-evaluating-the-impact-of-a-dietary-supplement-containing-humic-and-fulvic-acid-on-epigenetic-markers-of-biological-age-detoxification-inflammation-and-oxidative-stress-100640688","NCT07579845","Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress","Inclusion Criteria:\n\n1. Adult females or males age ≥ 40 years\n2. Ability to read and speak English\n\nExclusion Criteria:\n\n1. Current use of a dietary supplement containing fulvic or humic acid\n2. Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella\n3. Known allergies to any ingredients in the product\n4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks\n5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol\n6. Participants unable to provide consent",true,"40 Years",{"count":96,"type":20},60,[23],"The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.",[100,101,102],"Detoxification","Inflammation","Biological Aging","2026-05-27",{"date":105,"type":32},"2026-05-29",{"date":107,"type":32},"2026-05-05",{"date":109,"type":20},"2026-09",{"name":38,"class":39},{"id":112,"slug":113,"hasResults":11,"nctId":114,"briefTitle":115,"officialTitle":116,"acronym":4,"eligibilityCriteria":117,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":118,"targetDuration":4,"studyType":21,"phases":119,"briefSummary":120,"conditions":121,"keywords":4,"overallStatus":78,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":127,"locationsCount":40},"100620285","terraflora-daily-care-and-gastrointestinal-health-100620285","NCT07355634","Terraflora Daily Care and Gastrointestinal Health","A Randomized, Placebo-Controlled Trial Evaluating the Impact of a Synbiotic Dietary Supplement on Markers of Gastrointestinal Health","Inclusion Criteria:\n\n1. Adult males or females age ≥ 25 years\n2. Ability to read and speak English\n3. Dysbiosis (≥3 on GA-Map Dysbiosis Score) on a stool test (GI360 Profile, Doctor's Data, St. Charles, Illinois)\n\nExclusion Criteria:\n\n1. Daily use within the past month of any probiotic or prebiotic supplement\n2. Current diagnosis of inflammatory bowel disease, including Crohn's or ulcerative colitis\n3. Current daily usage of non-steroidal anti-inflammatory drugs (NSAID), proton pump inhibitors (PPI), or antibiotic medications\n4. Current daily tobacco smoker\n5. Known allergies to any substance in the study products\n6. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks\n7. Current diagnosis of any other chronic health condition (e.g., cancer, chronic kidney disease) deemed clinically contraindicated for the study protocol\n8. Current participation in another clinical trial\n9. Participants unable to provide consent",{"count":19,"type":20},[23],"A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.",[53],{"date":123,"type":32},"2026-05-11",{"date":125,"type":32},"2026-01-12",{"date":109,"type":20},{"name":38,"class":39},""]